Murphy & Mullick Capital Management’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32K Hold
655
0.02% 353
2026
Q1
$25.7K Buy
655
+1
+0.2% +$39 0.02% 369
2025
Q4
$23.7K Hold
654
0.02% 383
2025
Q3
$25K Hold
654
0.02% 360
2025
Q2
$23.9K Hold
654
0.02% 355
2025
Q1
$23.7K Buy
654
+1
+0.2% +$39 0.02% 346
2024
Q4
$25.7K Buy
+653
New +$25.4K 0.02% 328

Other funds holding BOUT

Murphy & Mullick Capital Management's BOUT Position: Q2 2026 in Review

Murphy & Mullick Capital Management held its CapForce IBD Breakout Opportunities ETF (BOUT) position steady in Q2 2026 at 655 shares worth $32K. The position accounts for 0.02% of the portfolio, ranked #353.

Murphy & Mullick Capital Management first reported a position in BOUT in Q4 2024 and has held it in 7 quarters since. 12 funds tracked by Wall St. Rank hold BOUT as of Q2 2026.

  • Murphy & Mullick Capital Management held 655 shares of CapForce IBD Breakout Opportunities ETF worth $32K as of Q2 2026.
  • Murphy & Mullick Capital Management left its CapForce IBD Breakout Opportunities ETF share count unchanged in Q2 2026.
  • CapForce IBD Breakout Opportunities ETF made up 0.02% of Murphy & Mullick Capital Management's portfolio in Q2 2026, its #353 holding.
  • Murphy & Mullick Capital Management first reported a position in CapForce IBD Breakout Opportunities ETF in Q4 2024 and has held it in 7 quarters since.
  • 12 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q2 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.